A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors

IBI308 in Subjects With Advanced/Metastatic Solid Malignancies

NCT03568539 ·Status: COMPLETED ·Phase: PHASE1

Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion

NCT04794699 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors

NCT04972981 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of AK127 in Patients With Advanced Solid Tumors

NCT05393063 ·Status: UNKNOWN ·Phase: PHASE1

A Study of GDC-0941 in Participants With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable

NCT00876109 ·Status: COMPLETED ·Phase: PHASE1

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

NCT03621982 ·Status: TERMINATED ·Phase: PHASE1

Study of BC3195 Monotherapy in Patients With Advanced Solid Tumors

NCT05957471 ·Status: UNKNOWN ·Phase: PHASE1

A Study of GDC-0941 in Patients With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable

NCT00876122 ·Status: COMPLETED ·Phase: PHASE1

JYB1907 in Subjects With Advanced Solid Tumors

NCT05821595 ·Status: UNKNOWN ·Phase: PHASE1

A Study of BA1202 in Patients With Advanced Solid Tumors

NCT05909241 ·Status: RECRUITING ·Phase: PHASE1

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

NCT03422679 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study of Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

NCT00968981 ·Status: COMPLETED ·Phase: PHASE1

Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors

NCT06773507 ·Status: RECRUITING ·Phase: PHASE1

Study of XL820 in Adults With Solid Tumors

NCT00129571 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors

NCT03530397 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Clinical Trial to Evaluate the PK and Safety of BCD-201 and Keytruda® in Patients With Advanced Malignancies

NCT05739006 ·Status: UNKNOWN ·Phase: PHASE1

Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors

NCT07299747 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Safety, Tolerability, Pharmacokinetics, and Antitumor Study of ADCT-601 to Treat Advanced Solid Tumors

NCT03700294 ·Status: TERMINATED ·Phase: PHASE1

A Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors

NCT03762447 ·Status: COMPLETED ·Phase: PHASE1

A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors

NCT01875705 ·Status: COMPLETED ·Phase: PHASE1

Testing the Safety of CB-5339 in Patients With Cancer

NCT04372641 ·Status: WITHDRAWN ·Phase: PHASE1

Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression

NCT05163041 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors

NCT06771622 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Study of DXC014 in Patients With Advanced Solid Tumors.

NCT07177937 ·Status: RECRUITING ·Phase: PHASE1

Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.

NCT03891953 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1